These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9552305)

  • 1. Solubility enhancement of a bisnaphthalimide tumoricidal agent, DMP 840, through complexation.
    Raghavan KS; Nemeth GA; Gray DB; Hussain MA
    Pharm Dev Technol; 1996 Oct; 1(3):231-8. PubMed ID: 9552305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic compatibility testing of DMP 840, an experimental antitumor agent.
    Rubino JT; Nellore R; Parmar B
    PDA J Pharm Sci Technol; 1997; 51(3):130-6. PubMed ID: 9203827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization of poorly soluble compounds using 2-pyrrolidone.
    Jain P; Yalkowsky SH
    Int J Pharm; 2007 Sep; 342(1-2):1-5. PubMed ID: 17570624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stacking complexation by nicotinamide: a useful way of enhancing drug solubility.
    Sanghvi R; Evans D; Yalkowsky SH
    Int J Pharm; 2007 May; 336(1):35-41. PubMed ID: 17145146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubility enhancement of poorly water soluble domperidone by complexation with the large ring cyclodextrin.
    Ismail A; Kerdpol K; Rungrotmongkol T; Tananuwong K; Ueno T; Ekasit S; Muangsin N; Krusong K
    Int J Pharm; 2021 Sep; 606():120909. PubMed ID: 34298103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubilization by cosolvents I: organic solutes in propylene glycol-water mixtures.
    Yalkowsky SH; Rubino JT
    J Pharm Sci; 1985 Apr; 74(4):416-21. PubMed ID: 3999002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.
    Miyake K; Hirayama F; Uekama K
    J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclodextrin complexation on aqueous solubility and photostability of phenothiazine.
    Lutka A
    Pharmazie; 2000 Feb; 55(2):120-3. PubMed ID: 10723770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization of flavopiridol by pH control combined with cosolvents, surfactants, or complexants.
    Li P; Tabibi SE; Yalkowsky SH
    J Pharm Sci; 1999 Sep; 88(9):945-7. PubMed ID: 10479359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexation of nifedipine with substituted phenolic ligands.
    Boje KM; Sak M; Fung HL
    Pharm Res; 1988 Oct; 5(10):655-9. PubMed ID: 3244619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melarsoprol-cyclodextrins inclusion complexes.
    Gibaud S; Zirar SB; Mutzenhardt P; Fries I; Astier A
    Int J Pharm; 2005 Dec; 306(1-2):107-21. PubMed ID: 16253447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubility enhancement of nucleosides and structurally related compounds by complex formation.
    Chen AX; Zito SW; Nash RA
    Pharm Res; 1994 Mar; 11(3):398-401. PubMed ID: 8008706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased shelf-life of fosphenytoin: solubilization of a degradant, phenytoin, through complexation with (SBE)7m-beta-CD.
    Narisawa S; Stella VJ
    J Pharm Sci; 1998 Aug; 87(8):926-30. PubMed ID: 9687335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents.
    Kawakami K; Oda N; Miyoshi K; Funaki T; Ida Y
    Eur J Pharm Sci; 2006 May; 28(1-2):7-14. PubMed ID: 16406526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium.
    Ungaro F; Giovino C; Catanzano O; Miro A; Mele A; Quaglia F; La Rotonda MI
    Int J Pharm; 2011 Feb; 404(1-2):49-56. PubMed ID: 21056648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system.
    Men K; Liu W; Li L; Duan X; Wang P; Gou M; Wei X; Gao X; Wang B; Du Y; Huang M; Chen L; Qian Z; Wei Y
    Nanoscale; 2012 Oct; 4(20):6425-33. PubMed ID: 22955255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies.
    Phillip Lee YH; Sathigari S; Jean Lin YJ; Ravis WR; Chadha G; Parsons DL; Rangari VK; Wright N; Babu RJ
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1113-20. PubMed ID: 19640249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies.
    Ribeiro L; Carvalho RA; Ferreira DC; Veiga FJ
    Eur J Pharm Sci; 2005 Jan; 24(1):1-13. PubMed ID: 15626573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.